Status:
UNKNOWN
Treatment of Age-related Macular Degeneration Using Retinal Stem and Progenitor Cells
Lead Sponsor:
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
Collaborating Sponsors:
Belarusian State Medical University
Conditions:
Age-Related Macular Degeneration
Eligibility:
All Genders
18-80 years
Phase:
PHASE1
PHASE2
Brief Summary
Treatment of age-related macular degeneration using retinal stem and progenitor cells
Detailed Description
The aim of the project is to develop a biomedical cell product based on retinal pigment epithelium cells for highly effective treatment age-related macular degeneration; to conduct the clinical trials...
Eligibility Criteria
Inclusion
- Clinical diagnosis of age-related macular degeneration
- The patient can read, understand, follow the examination procedures and complete, if necessary, the required documentation
- Written informed consent
Exclusion
- The presence of any malignant tumor within the last 5 years
- Acute or chronic diseases in the stage of decompensation
- Chronic infectious diseases: HIV, viral hepatitis B, C, tuberculosis
- Patients who are pregnant, breastfeeding, or fertile patients who are not using adequate contraceptive methods
- Chronic and protracted mental disorders, all diseases with the presence of the syndrome of dependence on alcohol, drugs and psychoactive substances, any other condition that makes the patient unable to understand the nature, extent and possible consequences of the study or, in the opinion of the researcher, prevents the patient from observing and performing protocol
- Patients are unable or unwilling to give written informed consent and / or follow research procedures
- Any other medical condition that, in the opinion of the investigator, may be associated with an increased risk to the patient or may affect the outcome or evaluation of the study
Key Trial Info
Start Date :
March 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05187104
Start Date
March 1 2022
End Date
December 31 2023
Last Update
September 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
Minsk, Belarus, 220072